234 related articles for article (PubMed ID: 21538846)
21. Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review.
Pandiella-Alonso A; Díaz-Rodríguez E; Sanz E
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32878230
[TBL] [Abstract][Full Text] [Related]
22. Unexpected Toxicity of Green Tea Polyphenols in Combination with the
Rojo MÁ; Garrosa M; Jiménez P; Girbés T; Garcia-Recio V; Cordoba-Diaz M; Cordoba-Diaz D
Toxins (Basel); 2020 Aug; 12(9):. PubMed ID: 32842591
[TBL] [Abstract][Full Text] [Related]
23. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
[TBL] [Abstract][Full Text] [Related]
24. Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup
Gu Y; Moroy G; Paul JL; Rebillat AS; Dierssen M; de la Torre R; Cieuta-Walti C; Dairou J; Janel N
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092951
[TBL] [Abstract][Full Text] [Related]
25. Changes in the Biotransformation of Green Tea Catechins Induced by Different Carbon and Nitrogen Sources in
Fang X; Du M; Liu T; Fang Q; Liao Z; Zhong Q; Chen J; Meng X; Zhou S; Wang J
Front Microbiol; 2019; 10():2521. PubMed ID: 31736934
[TBL] [Abstract][Full Text] [Related]
26. Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors.
Liu C; Li P; Qu Z; Xiong W; Liu A; Zhang S
Molecules; 2019 May; 24(9):. PubMed ID: 31058847
[TBL] [Abstract][Full Text] [Related]
27. Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy.
Deng P; Hu C; Xiong Z; Li Y; Jiang J; Yang H; Tang Y; Cao L; Lu R
Cancer Manag Res; 2019; 11():2425-2439. PubMed ID: 30988640
[TBL] [Abstract][Full Text] [Related]
28. Selected Office Based Anticancer Treatment Strategies.
Stoff JA
J Oncol; 2019; 2019():7462513. PubMed ID: 30766601
[TBL] [Abstract][Full Text] [Related]
29. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
Negri A; Naponelli V; Rizzi F; Bettuzzi S
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563268
[TBL] [Abstract][Full Text] [Related]
30. (-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity.
Kawabata T; Otsuka T; Fujita K; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2018 Dec; 42(6):3149-3156. PubMed ID: 30272256
[TBL] [Abstract][Full Text] [Related]
31. Repression of IGF-I-induced osteoblast migration by (-)-epigallocatechin gallate through p44/p42 MAP kinase signaling.
Kawabata T; Tokuda H; Sakai G; Fujita K; Matsushima-Nishiwaki R; Otsuka T; Kozawa O
Biomed Rep; 2018 Oct; 9(4):318-326. PubMed ID: 30233784
[TBL] [Abstract][Full Text] [Related]
32. Possible Mechanisms of Green Tea and Its Constituents against Cancer.
Shirakami Y; Shimizu M
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205425
[TBL] [Abstract][Full Text] [Related]
33. Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: a retrospective study.
Horibe Y; Adachi S; Ohno T; Goto N; Okuno M; Iwama M; Yamauchi O; Kojima T; Saito K; Ibuka T; Yasuda I; Araki H; Moriwaki H; Shimizu M
Oncotarget; 2017 Nov; 8(58):97862-97870. PubMed ID: 29228657
[TBL] [Abstract][Full Text] [Related]
34. Epigallocatechin-3-gallate inhibits growth and induces apoptosis in esophageal cancer cells through the demethylation and reactivation of the p16 gene.
Meng J; Tong Q; Liu X; Yu Z; Zhang J; Gao B
Oncol Lett; 2017 Jul; 14(1):1152-1156. PubMed ID: 28693288
[TBL] [Abstract][Full Text] [Related]
35. (-)-Epigallocatechin gallate but not chlorogenic acid upregulates osteoprotegerin synthesis through regulation of bone morphogenetic protein-4 in osteoblasts.
Fujita K; Otsuka T; Yamamoto N; Kainuma S; Ohguchi R; Kawabata T; Sakai G; Kuroyanagi G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Exp Ther Med; 2017 Jul; 14(1):417-423. PubMed ID: 28672948
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin gallate has pleiotropic effects on transmembrane signaling by altering the embedding of transmembrane domains.
Ye F; Yang C; Kim J; MacNevin CJ; Hahn KM; Park D; Ginsberg MH; Kim C
J Biol Chem; 2017 Jun; 292(24):9858-9864. PubMed ID: 28487468
[TBL] [Abstract][Full Text] [Related]
37. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Farabegoli F; Govoni M; Spisni E; Papi A
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
[TBL] [Abstract][Full Text] [Related]
38. Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation.
Shirakami Y; Ohnishi M; Sakai H; Tanaka T; Shimizu M
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28445390
[TBL] [Abstract][Full Text] [Related]
39. Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.
Naponelli V; Ramazzina I; Lenzi C; Bettuzzi S; Rizzi F
Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379200
[TBL] [Abstract][Full Text] [Related]
40. Cancer Preventive Activities of Tea Catechins.
Yang CS; Wang H
Molecules; 2016 Dec; 21(12):. PubMed ID: 27941682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
